All In Biotech

Free tool

FAERS Monitor: Definity

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021064 or its brand name (Definity, Perflutren). Reports on generic versions are filed under their own applications.

Reports

5,709

Serious

1,899

33% of reports

Hospitalization

401

Death reported

116

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • back pain2,424
  • dyspnoea800
  • muscle spasms755
  • pain in extremity504
  • flushing414
  • chest pain403
  • headache382
  • dizziness331
  • urticaria305
  • neck pain304
  • nausea274
  • arthralgia244
  • pruritus215
  • erythema213
  • anaphylactic reaction205

Reports by year received

View as table
YearReports
2004135
2005195
2006342
2007628
2008279
200935
201031
201115
201223
201329
201420
201564
2016244
2017222
2018187
2019209
2020252
2021251
2022501
2023528
2024509
2025612
2026398

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,450 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
back painSignal2,42438.837.789,368
neck painSignal30420.118.15,497
muscle spasmsSignal75515.214.210,059
flushingSignal41415.113.75,425
anaphylactic reactionSignal20513.712.02,401
chest painSignal4038.07.32,490
urticariaSignal3056.76.01,488
pain in extremitySignal5046.35.82,275
dyspnoeaSignal8005.24.92,790
erythemaSignal2133.83.3445
dizzinessSignal3312.42.2288
headacheSignal3822.22.0271
arthralgiaSignal2442.21.9154
pruritusSignal2152.11.8119
nausea2741.31.117

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.